Welcome to LookChem.com Sign In|Join Free
  • or
3-Butoxy-4-methoxybenzoic acid, with the molecular formula C12H16O4, is an arylcarboxylic acid that serves as a versatile chemical intermediate. It is recognized for its role in the synthesis of pharmaceuticals, agrochemicals, UV absorbers, antioxidants, dyes, pigments, and other organic compounds. Its applications extend to personal care products and as a stabilizer in polymers and coatings.

66924-20-7

Post Buying Request

66924-20-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

66924-20-7 Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
3-Butoxy-4-methoxybenzoic acid is used as a chemical intermediate for the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides.
Used in UV Absorbers and Antioxidants Production:
3-Butoxy-4-methoxybenzoic acid is utilized as a key component in the production of UV absorbers and antioxidants, which are essential for protecting materials from the harmful effects of ultraviolet radiation.
Used in Dyes and Pigments Manufacturing:
This chemical compound is used as a raw material in the manufacture of dyes and pigments, playing a crucial role in the coloration of various products.
Used in Personal Care Products:
3-Butoxy-4-methoxybenzoic acid is incorporated into the formulation of personal care products, enhancing their performance and quality.
Used as a Stabilizer in Polymers and Coatings:
3-Butoxy-4-methoxybenzoic acid serves as a stabilizer in polymers and coatings, improving their durability and resistance to environmental factors.

Check Digit Verification of cas no

The CAS Registry Mumber 66924-20-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,9,2 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 66924-20:
(7*6)+(6*6)+(5*9)+(4*2)+(3*4)+(2*2)+(1*0)=147
147 % 10 = 7
So 66924-20-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O4/c1-3-4-7-16-11-8-9(12(13)14)5-6-10(11)15-2/h5-6,8H,3-4,7H2,1-2H3,(H,13,14)

66924-20-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-BUTOXY-4-METHOXYBENZOIC ACID

1.2 Other means of identification

Product number -
Other names Benzoic acid,3-butoxy-4-methoxy

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66924-20-7 SDS

66924-20-7Relevant academic research and scientific papers

Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model

Yang, Kan,Nong, Keyi,Gu, Qinlan,Dong, Jibin,Wang, Jinxin

, p. 389 - 400 (2018/04/12)

Acid sphingomyelinase (ASM) has been shown to be involved in many physiological processes, emerging to be a promising drug target. In this study, we constructed a ligand-based pharmacophore model of ASM inhibitors and applied this model to optimize the lead compound α-mangostin, a known inhibitor of ASM. 23 compounds were designed and evaluated in vitro for ASM inhibition, of these, 10 compounds were found to be more potent than α-mangostin. This high hit ratio confirmed that the presented model is very effective and practical. The most potent hit, 1c, was found to selectively and competitively inhibit the enzyme and inhibit the generation of ceramide in a dose-dependent manner. Furthermore, 1c showed favorable anti-apoptosis and anti-inflammatory activity. Interactions with key residues and the Zn2+ cofactor of 1c were found by docking simulation. These results provide promising leads and important guidance for further development of efficient ASM inhibitors and drug candidates.

HETEROAROMATIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF

-

Paragraph 00327, (2015/11/10)

Provided herein are novel heteroaromatic derivatives, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a prodrug, a pharmaceutically acceptable salt or a prodrug thereof, and pharmaceutical compositions containing such compounds. Also provided herein are uses of such compounds or pharmaceutical compositions thereof in the manufacture of a medicament for treating respiratory diseases, especially chronic obstructive pulmonary disease (COPD).

Discovery and structural modification of 1-phenyl-3-(1-phenylethyl)urea derivatives as inhibitors of complement

Zhang, Mei,Yang, Xiao-Ying,Tang, Wei,Groeneveld, Tom W. L.,He, Pei-Lan,Zhu, Feng-Hua,Li, Jia,Lu, Wei,Blom, Anna M.,Zuo, Jian-Ping,Nan, Fa-Jun

supporting information; experimental part, p. 317 - 321 (2012/05/20)

A series of 1-phenyl-3-(1-phenylethyl)urea derivatives were identified as novel and potent complement inhibitors through structural modification of the original compound from high-throughput screening. Various analogues (7 and 13-15) were synthesized and identified as complement inhibitors, with the introduction of a five- or six-carbon chain (7c, 7d, 7k, 7l, and 7o) greatly improving their activity. Optimized compound 7l has an excellent inhibition activity with IC50 values as low as 13 nM. We demonstrated that the compound 7l inhibited C9 deposition through the classical, the lectin, and the alternative pathways but had no influence on C3 and C4 depositions.

Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogues

Ashton, Michael J.,Cook, David C.,Fenton, Garry,Karlsson, Jan-Anders,Palfreyman, Malcolm N.,et al.

, p. 1696 - 1703 (2007/10/02)

The syntheses and biological activities of a number of benzamide derivatives, designed from rolipram, which are selective inhibitors of cyclic AMP-specific phosphodiesterase (PDE IV), are described.The effects of changes to the alkoxy groups, amide linkag

Influence of lateral alkoxy substitution on mesomorphic properties of copper complexes

Berdague, Philippe,Perez, Felix,Courtieu, Jacques,Bayle, Jean-Pierre

, p. 335 - 343 (2007/10/02)

Coordination complexes between copper and some lateral alkoxy chain-substituted N-(4-(4'-alkoxybenzoyloxy)salicylidene)-4-n-butylaniline have been synthesized.The lateral chain was introduced on the outer ring bearing the ester function.In the case of a 3,4-disubstitution, the mesomorphic behavior is related to the number of carbons in the terminal chain.If this is too small, the mesomorphic properties of the complexes disappear.In contrast, copper complexes are liquid crystalline and show more ordered phases by comparison with the free ligand.In case of a 2,4-disubstitution, the phases are nematic and the clearing temperatures are near room temperature, but the observed phases are essentially monotropic for the ligands, as well as for the complexes.Keywords: nematic / copper complex / lateral substitution / Schiff base

Selective etherification of polyhydroxybenzenes using PEG 200 as solvent or cosolvent

Berdague, P.,Perez, F.,Courtieu, J.,Bayle, J. P.

, p. 475 - 480 (2007/10/02)

The monoalkylation of hydroquinone is performed using PEG 200 as a solvent or a cosolvent.The effect on the selectivity of the base strength, the temperature, and the percentage of cosolvent are discussed.The substituted phenols were found to behave differently upon etherification.When a carboxylic function is present in the ring, the hydroxybenzoic acids were selectively etherified using pure PEG and sodium hydroxyde as a base.Substituted diphenols were selectively etherified using a mixture of PEG and dioxan and potassium hydrogencarbonate as a base.Keywords - etherification / selectivity / polyhydroxybenzenes / polyethylene glycol

An improved method for the synthesis of 5-aryl-3-methyl-2-methylimino-1,3,4-oxadiazoles

Kane,Staeger

, p. 1 - 11 (2007/10/02)

5-Aryl-3-methyl-2-methylimino-1,3,4-oxadiazoles were prepared in 54-81% yields by the mercuric oxide-induced cyclizations of 1-aroyl-2,4,-dimethylthiosemicarbazides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 66924-20-7